Antibodies, Monoclonal
Showing 7276 - 7300 of 7,894
Osteoarthritis, Pain Trial in London Bridge (MEDI-578, Placebo for MEDI-578)
Terminated
- Osteoarthritis
- Pain
- MEDI-578
- Placebo for MEDI-578
-
London Bridge, Greater London, United KingdomResearch Site
Jan 28, 2013
Interstitial Lung Disease Trial in Barcelona (Biopsy by cryoprobes, Biopsy with conventional forceps)
Completed
- Interstitial Lung Disease
- Biopsy by cryoprobes
- Biopsy with conventional forceps
-
Barcelona, SpainHospital de la Sanrta Creu i Sant Pau
Jan 21, 2013
Esophageal Cancer Trial in United Kingdom (biological, drug, radiation)
Unknown status
- Esophageal Cancer
- cetuximab
- +3 more
-
Birmingham, England, United Kingdom
- +54 more
Dec 17, 2012
Arthritis, Rheumatoid Trial (Part A, Part B)
Completed
- Arthritis, Rheumatoid
- Part A
- Part B
- (no location specified)
Nov 8, 2012
Elitek (Rasburicase) Immuno-Monitoring Study
Terminated
- Tumor Lysis Syndrome
-
Valhalla, New York
- +3 more
Jan 30, 2013
Epidermal Growth Factor Receptor Inhibitor Therapy in Skin of
Completed
- Solid Tumor
- enzyme inhibitor therapy
- +4 more
-
Nashville, TennesseeVanderbilt-Ingram Cancer Center
Aug 31, 2012
Renal Cell Cancer Trial in Houston (Fludarabine, Melphalan, Cyclophosphamide)
Terminated
- Renal Cell Cancer
- Fludarabine
- +3 more
-
Houston, TexasU.T. M.D. Anderson Cancer Center
Feb 26, 2013
HTLV-I Infection, T Cell Leukemia Trial run by the NCI (daclizumab)
Completed
- HTLV-I Infection
- T Cell Leukemia
- daclizumab
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 13, 2012
Lymphoma Trial in Canada (rituximab, bortezomib, cyclophosphamide)
Completed
- Lymphoma
- rituximab
- +4 more
-
Edmonton, Alberta, Canada
- +18 more
Nov 26, 2012
Plasmodium Falciparum Malaria Trial in Houston (Aluminum Phosphate, Placebo, EBA-175 RII-NG Malaria Vaccine)
Completed
- Plasmodium Falciparum Malaria
- Aluminum Phosphate
- +2 more
-
Houston, TexasBaylor College of Medicine - Molecular Virology and Microbiology
Apr 11, 2013
Multiple Myeloma Trial in United States (Elotuzumab (HuLuc63))
Terminated
- Multiple Myeloma
- Elotuzumab (HuLuc63)
-
Los Angeles, California
- +7 more
Aug 22, 2012
Bone Mineralization Defect Trial in Loma Linda, Los Angeles (Vitamin D2)
Unknown status
- Bone Mineralization Defect
- Vitamin D2
-
Loma Linda, California
- +1 more
Feb 22, 2013
Prophylaxis of Venous Thromboembolic Events Trial in Worldwide (TB-402, Rivaroxaban)
Completed
- Prophylaxis of Venous Thromboembolic Events
-
Linz, Austria
- +35 more
Aug 22, 2012
Respiratory Syncytial Virus Infections, Chronic Lung Disease and <= 24 Months of Age or, Premature With Gestational Age <=35
Completed
- Respiratory Syncytial Virus Infections
- +2 more
- Motavizumab, palivizumab
- +2 more
-
Garran, Australian Capital Territory, Australia
- +18 more
Nov 13, 2012
Metastatic Cancer, Prostate Cancer Trial in Worldwide (strontium chloride Sr 89)
Completed
- Metastatic Cancer
- Prostate Cancer
- strontium chloride Sr 89
-
Brussels, Belgium
- +20 more
Sep 20, 2012
Crohn's Disease, Colitis, Intestinal Disease Trial in Canada, United States (anti-Interferon-gamma mAb)
Completed
- Crohn's Disease
- +4 more
- anti-Interferon-gamma monoclonal antibody
-
Anaheim, California
- +18 more
Mar 9, 2012
Follicular Lymphoma Trial in Pavia (Immunochemo, in vivo purging and autrotransplant)
Completed
- Follicular Lymphoma
- Immunochemotherapy, in vivo purging and autrotransplant
-
Pavia, ItalyDivision of Hematology, IRCCS Policlinico S. Matteo, University
Oct 26, 2012
Lymphoma Trial in Los Angeles (bortezomib + rituximab)
Completed
- Lymphoma
- bortezomib + rituximab
-
Los Angeles, CaliforniaJonsson Comprehensive Cancer Center at UCLA
Oct 3, 2012
Respiratory Virus Infections In Children Undergoing
Completed
- Respiratory Virus Infections
- Nasopharyngeal Washes
- +2 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Sep 6, 2012
Glomerulonephritis, Membranoproliferative Trial in Rochester (Rituximab)
Completed
- Glomerulonephritis, Membranoproliferative
-
Rochester, MinnesotaMayo Clinic
Jan 15, 2013
Lymphoma, Mantle-Cell Trial in Vicenza (Rituximab, Bendamustine, Cytarabine)
Completed
- Lymphoma, Mantle-Cell
- Rituximab, Bendamustine, Cytarabine
-
Vicenza, VI, ItalyDepartment of Hematology, Ospedale San Bortolo
Sep 25, 2012
Lupus Erythematosus, Cutaneous, Lupus Erythematosus, Systemic Trial (1 mg/kg CNTO 136, 4 mg/kg CNTO 136, 10 mg/kg CNTO 136)
Completed
- Lupus Erythematosus, Cutaneous
- Lupus Erythematosus, Systemic
- 1 mg/kg CNTO 136
- +3 more
- (no location specified)
Oct 5, 2012